Troglitazone enhances glucose uptake induced by α-adrenoceptor stimulation via phosphatidylinositol 3-kinase in rat heart

Jun Yoshioka, Hideo Kusuoka, Kenichi Imahashi, Katsuji Hashimoto, Masatsugu Hori, Taichiro Terakawa, Tsunehiko Nishimura

Research output: Contribution to journalArticle

Abstract

1. Thiazolidinedione-derived agents have been reported to act as insulin sensitizers by augmenting insulin-dependent stimulation of phosphatidylinositol 3-kinase (PI3K) activity in a specific manner. It has been suggested that α-adrenoceptor stimulation mediates glucose uptake through PI3K in the heart. 2. To elucidate whether the thiazolidinedione-derived agent troglitazone (TRO) affects glucose uptake induced by α-adrenoceptor stimulation through PI3K, the rate of glucose uptake was quantified from the rate of accumulation of sugar phosphate (d[SP]/dt) using [31P] nuclear magnetic resonance spectroscopy after substitution of glucose with 2-deoxyglucose in rat perfused heart. Hearts were stimulated with 100 μmol/L phenylephrine plus 10 μmol/L propranolol (α-adrenoceptor stimulation), or 1 μmol/L isoproterenol plus 10 μmol/L phentolamine (β-adrenoceptor stimulation). 3. The d[SP]/dt in the α- and β-adrenoceptor-stimulated groups (0.45 ± 0.06 and 0.42 ± 0.04 μmol/min per g, respectively) was higher than that of the control group (0.27 ± 0.02 μmol/min per g; P <0.01). The addition of 2 μg/mL troglitazone to α-adrenoceptor stimulation augmented d[SP]/dt (0.72 ± 0.08 μmol/min per g; P <0.05 vs the α-adrenoceptor-stimulated group), which was effectively blocked by 3 μmol/L wortmannin (0.35 ± 0.06 μmol/min per g; P <0.01 vs troglitazone + α-adrenoceptor stimulation group). However, addition of troglitazone to β-adrenoceptor stimulation did not alter d[SP]/dt (0.33 ± 0.02 μmol/min per g; P = NS vs the β-adrenoceptor-stimulated group). 4. These results indicate that troglitazone acutely enhances α-adrenoceptor stimulation on glucose uptake through a PI3K-dependent pathway, thus possibly improving glucose utilization in a catecholamine-released state.

Original languageEnglish (US)
Pages (from-to)752-757
Number of pages6
JournalClinical and Experimental Pharmacology and Physiology
Volume28
Issue number9
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

troglitazone
Phosphatidylinositol 3-Kinase
Adrenergic Receptors
Glucose
Sugar Phosphates
Insulin

Keywords

  • Catecholamine
  • Glucose uptake
  • Phosphoinositide 3-kinase
  • Rat isolated heart
  • Troglitazone

ASJC Scopus subject areas

  • Physiology
  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Troglitazone enhances glucose uptake induced by α-adrenoceptor stimulation via phosphatidylinositol 3-kinase in rat heart. / Yoshioka, Jun; Kusuoka, Hideo; Imahashi, Kenichi; Hashimoto, Katsuji; Hori, Masatsugu; Terakawa, Taichiro; Nishimura, Tsunehiko.

In: Clinical and Experimental Pharmacology and Physiology, Vol. 28, No. 9, 2001, p. 752-757.

Research output: Contribution to journalArticle

Yoshioka, Jun ; Kusuoka, Hideo ; Imahashi, Kenichi ; Hashimoto, Katsuji ; Hori, Masatsugu ; Terakawa, Taichiro ; Nishimura, Tsunehiko. / Troglitazone enhances glucose uptake induced by α-adrenoceptor stimulation via phosphatidylinositol 3-kinase in rat heart. In: Clinical and Experimental Pharmacology and Physiology. 2001 ; Vol. 28, No. 9. pp. 752-757.
@article{51e910290a8d44429bc0e24003fc9b2f,
title = "Troglitazone enhances glucose uptake induced by α-adrenoceptor stimulation via phosphatidylinositol 3-kinase in rat heart",
abstract = "1. Thiazolidinedione-derived agents have been reported to act as insulin sensitizers by augmenting insulin-dependent stimulation of phosphatidylinositol 3-kinase (PI3K) activity in a specific manner. It has been suggested that α-adrenoceptor stimulation mediates glucose uptake through PI3K in the heart. 2. To elucidate whether the thiazolidinedione-derived agent troglitazone (TRO) affects glucose uptake induced by α-adrenoceptor stimulation through PI3K, the rate of glucose uptake was quantified from the rate of accumulation of sugar phosphate (d[SP]/dt) using [31P] nuclear magnetic resonance spectroscopy after substitution of glucose with 2-deoxyglucose in rat perfused heart. Hearts were stimulated with 100 μmol/L phenylephrine plus 10 μmol/L propranolol (α-adrenoceptor stimulation), or 1 μmol/L isoproterenol plus 10 μmol/L phentolamine (β-adrenoceptor stimulation). 3. The d[SP]/dt in the α- and β-adrenoceptor-stimulated groups (0.45 ± 0.06 and 0.42 ± 0.04 μmol/min per g, respectively) was higher than that of the control group (0.27 ± 0.02 μmol/min per g; P <0.01). The addition of 2 μg/mL troglitazone to α-adrenoceptor stimulation augmented d[SP]/dt (0.72 ± 0.08 μmol/min per g; P <0.05 vs the α-adrenoceptor-stimulated group), which was effectively blocked by 3 μmol/L wortmannin (0.35 ± 0.06 μmol/min per g; P <0.01 vs troglitazone + α-adrenoceptor stimulation group). However, addition of troglitazone to β-adrenoceptor stimulation did not alter d[SP]/dt (0.33 ± 0.02 μmol/min per g; P = NS vs the β-adrenoceptor-stimulated group). 4. These results indicate that troglitazone acutely enhances α-adrenoceptor stimulation on glucose uptake through a PI3K-dependent pathway, thus possibly improving glucose utilization in a catecholamine-released state.",
keywords = "Catecholamine, Glucose uptake, Phosphoinositide 3-kinase, Rat isolated heart, Troglitazone",
author = "Jun Yoshioka and Hideo Kusuoka and Kenichi Imahashi and Katsuji Hashimoto and Masatsugu Hori and Taichiro Terakawa and Tsunehiko Nishimura",
year = "2001",
doi = "10.1046/j.1440-1681.2001.03515.x",
language = "English (US)",
volume = "28",
pages = "752--757",
journal = "Clinical and Experimental Pharmacology and Physiology",
issn = "0305-1870",
publisher = "Wiley-Blackwell",
number = "9",

}

TY - JOUR

T1 - Troglitazone enhances glucose uptake induced by α-adrenoceptor stimulation via phosphatidylinositol 3-kinase in rat heart

AU - Yoshioka, Jun

AU - Kusuoka, Hideo

AU - Imahashi, Kenichi

AU - Hashimoto, Katsuji

AU - Hori, Masatsugu

AU - Terakawa, Taichiro

AU - Nishimura, Tsunehiko

PY - 2001

Y1 - 2001

N2 - 1. Thiazolidinedione-derived agents have been reported to act as insulin sensitizers by augmenting insulin-dependent stimulation of phosphatidylinositol 3-kinase (PI3K) activity in a specific manner. It has been suggested that α-adrenoceptor stimulation mediates glucose uptake through PI3K in the heart. 2. To elucidate whether the thiazolidinedione-derived agent troglitazone (TRO) affects glucose uptake induced by α-adrenoceptor stimulation through PI3K, the rate of glucose uptake was quantified from the rate of accumulation of sugar phosphate (d[SP]/dt) using [31P] nuclear magnetic resonance spectroscopy after substitution of glucose with 2-deoxyglucose in rat perfused heart. Hearts were stimulated with 100 μmol/L phenylephrine plus 10 μmol/L propranolol (α-adrenoceptor stimulation), or 1 μmol/L isoproterenol plus 10 μmol/L phentolamine (β-adrenoceptor stimulation). 3. The d[SP]/dt in the α- and β-adrenoceptor-stimulated groups (0.45 ± 0.06 and 0.42 ± 0.04 μmol/min per g, respectively) was higher than that of the control group (0.27 ± 0.02 μmol/min per g; P <0.01). The addition of 2 μg/mL troglitazone to α-adrenoceptor stimulation augmented d[SP]/dt (0.72 ± 0.08 μmol/min per g; P <0.05 vs the α-adrenoceptor-stimulated group), which was effectively blocked by 3 μmol/L wortmannin (0.35 ± 0.06 μmol/min per g; P <0.01 vs troglitazone + α-adrenoceptor stimulation group). However, addition of troglitazone to β-adrenoceptor stimulation did not alter d[SP]/dt (0.33 ± 0.02 μmol/min per g; P = NS vs the β-adrenoceptor-stimulated group). 4. These results indicate that troglitazone acutely enhances α-adrenoceptor stimulation on glucose uptake through a PI3K-dependent pathway, thus possibly improving glucose utilization in a catecholamine-released state.

AB - 1. Thiazolidinedione-derived agents have been reported to act as insulin sensitizers by augmenting insulin-dependent stimulation of phosphatidylinositol 3-kinase (PI3K) activity in a specific manner. It has been suggested that α-adrenoceptor stimulation mediates glucose uptake through PI3K in the heart. 2. To elucidate whether the thiazolidinedione-derived agent troglitazone (TRO) affects glucose uptake induced by α-adrenoceptor stimulation through PI3K, the rate of glucose uptake was quantified from the rate of accumulation of sugar phosphate (d[SP]/dt) using [31P] nuclear magnetic resonance spectroscopy after substitution of glucose with 2-deoxyglucose in rat perfused heart. Hearts were stimulated with 100 μmol/L phenylephrine plus 10 μmol/L propranolol (α-adrenoceptor stimulation), or 1 μmol/L isoproterenol plus 10 μmol/L phentolamine (β-adrenoceptor stimulation). 3. The d[SP]/dt in the α- and β-adrenoceptor-stimulated groups (0.45 ± 0.06 and 0.42 ± 0.04 μmol/min per g, respectively) was higher than that of the control group (0.27 ± 0.02 μmol/min per g; P <0.01). The addition of 2 μg/mL troglitazone to α-adrenoceptor stimulation augmented d[SP]/dt (0.72 ± 0.08 μmol/min per g; P <0.05 vs the α-adrenoceptor-stimulated group), which was effectively blocked by 3 μmol/L wortmannin (0.35 ± 0.06 μmol/min per g; P <0.01 vs troglitazone + α-adrenoceptor stimulation group). However, addition of troglitazone to β-adrenoceptor stimulation did not alter d[SP]/dt (0.33 ± 0.02 μmol/min per g; P = NS vs the β-adrenoceptor-stimulated group). 4. These results indicate that troglitazone acutely enhances α-adrenoceptor stimulation on glucose uptake through a PI3K-dependent pathway, thus possibly improving glucose utilization in a catecholamine-released state.

KW - Catecholamine

KW - Glucose uptake

KW - Phosphoinositide 3-kinase

KW - Rat isolated heart

KW - Troglitazone

UR - http://www.scopus.com/inward/record.url?scp=0035724922&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035724922&partnerID=8YFLogxK

U2 - 10.1046/j.1440-1681.2001.03515.x

DO - 10.1046/j.1440-1681.2001.03515.x

M3 - Article

VL - 28

SP - 752

EP - 757

JO - Clinical and Experimental Pharmacology and Physiology

JF - Clinical and Experimental Pharmacology and Physiology

SN - 0305-1870

IS - 9

ER -